Understanding health disparities in uveitis and eye inflammation in the U.S.
Official title: Health Disparities in the Development, Persistence, and Progression of Uveitis and Ocular Inflammation in the United States
Funded at University of Southern California · NIH-10913463 · Data updated 2026-11-12
This study looks at how different health challenges can impact uveitis, a condition that can lead to blindness, and aims to find out what makes it worse for different groups of people, while also helping a surgeon learn new skills to better care for patients with uveitis.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | September 30, 2021 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $164,013 |
| NIH project number | 5K23EY032985-04 |
| Project ID | NIH-10913463 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with uveitis or those at risk for developing this condition, especially from diverse demographic backgrounds.
✕Less likely to help
Patients who do not have uveitis or related ocular inflammatory conditions may not benefit from this research.
What this research studies
This research investigates how health disparities affect the development and progression of uveitis, a significant cause of blindness. By utilizing multiple large databases, the project aims to identify risk factors associated with uveitis across different populations. The research will also provide training for a surgeon to enhance their skills in clinical informatics, which will ultimately improve patient care for those suffering from uveitis. The findings could lead to better understanding and management of this condition in diverse patient groups.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment strategies for patients with uveitis, particularly those from underserved populations.
How similar studies have gone: Previous research has shown success in using large databases to study health disparities, indicating that this approach is promising.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Toy, Brian — University of Southern California
- Study coordinator: Toy, Brian
Related research
Other NIH-funded projects on the same topics.
-
Adalimumab Dose Adjustment for Pediatric Uveitis in JIA
A pediatric study will test whether lowering how often kids with juvenile idiopathic arthritis–related uveitis take adalimumab can keep inflammation controlled while reducing side effects and cost.
-
Changing adalimumab dosing for children with juvenile arthritis–related eye inflammation
This project tries to see if giving lower or less frequent doses of adalimumab can keep eye inflammation under control in children with juvenile idiopathic arthritis.
-
Systemic and topical antiviral treatment for CMV anterior uveitis (STACCATO)
A new NIH-supported effort will test how well oral and eye-applied antiviral medicines control CMV-related anterior uveitis in affected patients.
-
Systemic and topical antiviral treatment for CMV anterior uveitis in patients
A patient-friendly look at using antiviral medicines to treat CMV-related eye inflammation and protect vision.
-
Systemic and topical antiviral treatment for CMV anterior uveitis
This project tests how oral and eye-drop antiviral medicines can help prevent vision loss from CMV-related eye inflammation in people with anterior uveitis.
-
Systemic and topical antiviral control of CMV anterior uveitis: TreatmentOutcomes
A patient-focused look at how CMV eye inflammation in adults could be treated with pills, eye drops, or other strategies to prevent vision loss.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.